InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
22.01
-0.29 (-1.30%)
At close: Feb 13, 2026

InventisBio Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
12,7297,6718,7067,636--
Market Cap Growth
64.46%-11.89%14.01%---
Enterprise Value
11,2166,0716,7285,265--
Last Close Price
22.0113.3015.1413.28--
PS Ratio
70.5145.4546.92---
PB Ratio
7.644.244.363.45--
P/TBV Ratio
7.654.244.363.45--
EV/Sales Ratio
62.1335.9736.27---
Debt / Equity Ratio
0.010.010.010.010.04-
Net Debt / Equity Ratio
-0.91-0.92-0.95-1.00-1.02-1.02
Net Debt / EBITDA Ratio
9.286.045.924.291.951.00
Net Debt / FCF Ratio
12.236.676.084.562.525.09
Asset Turnover
0.100.080.08---
Quick Ratio
21.1320.6513.2920.177.3722.52
Current Ratio
21.2820.7813.4120.417.5022.64
Return on Equity (ROE)
-6.84%-12.61%-13.48%-33.34%-42.22%-208.94%
Return on Assets (ROA)
-5.76%-8.60%-9.08%-20.63%-24.42%-115.73%
Return on Capital Employed (ROCE)
-10.00%-15.30%-16.30%-23.20%-51.70%-101.80%
Earnings Yield
-0.91%-3.13%-3.26%-6.33%--
FCF Yield
-0.97%-3.25%-3.61%-6.35%--
Buyback Yield / Dilution
-1.23%-0.26%-12.97%-10.91%0.25%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.